Twenty Years of Polymers: A Personal Perspective on Alpha-1 Antitrypsin Deficiency

No abstract is available for this paper.

• Publication year

  2013

• Venue

  COPD

• Publication date

  2013-03-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/15412555.2013.764401PMID 23527623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural Dynamics Associated with Intermediate Formation in an Archetypal Conformational Disease

  2012cited by this paper
• Genetically distinct subsets within ANCA-associated vasculitis.

  2012cited by this paper
• Encephalopathy with Neuroserpin Inclusion Bodies Presenting as Progressive Myoclonus Epilepsy and Associated with a Novel Mutation in the Proteinase Inhibitor 12 Gene

  2011cited by this paper
• Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells

  2011cited by this paper
• Molecular basis of α1‐antitrypsin deficiency revealed by the structure of a domain‐swapped trimer

  2011cited by this paper
• Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis

  2011cited by this paper
• Oxidation of Z α1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema.

  2011cited by this paper
• Characterisation of serpin polymers in vitro and in vivo.

  2011cited by this paper
• Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema

  2011cited by this paper
• ANCA-associated vasculitis is linked to carriage of the Z allele of α1 antitrypsin and its polymers

  2011cited by this paper
• The serpinopathies studying serpin polymerization in vivo.

  2011cited by this paper
• A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with α1‐antitrypsin deficiency

  2010cited by this paper
• Defining the mechanism of polymerization in the serpinopathies

  2010cited by this paper
• Dynamic local unfolding in the serpinalpha-1 antitrypsin provides a mechanism for loop insertion and polymerization

  2010cited by this paper
• pH‐dependent stability of neuroserpin is mediated by histidines 119 and 138; Implications for the control of β‐sheet A and polymerization

  2010cited by this paper
• Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.

  2010cited by this paper
• An Autophagy-Enhancing Drug Promotes Degradation of Mutant α1-Antitrypsin Z and Reduces Hepatic Fibrosis

  2010cited by this paper
• New Findings in PiZZ α1-Antitrypsin Deficiency-Related Panniculitis

  2009cited by this paper
• The 2.1-A crystal structure of native neuroserpin reveals unique structural elements that contribute to conformational instability.

  2009cited by this paper
• Crystallographic and Cellular Characterisation of Two Mechanisms Stabilising the Native Fold of α1-Antitrypsin: Implications for Disease and Drug Design

  2009cited by this paper
• Endoplasmic Reticulum-associated Degradation (ERAD) and Autophagy Cooperate to Degrade Polymerogenic Mutant Serpins*

  2009cited by this paper
• Conformational pathology of the serpins: themes, variations, and therapeutic strategies.

  2009cited by this paper
• alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies.

  2009cited by this paper
• Polymers and inflammation: disease mechanisms of the serpinopathies

  2008cited by this paper
• Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization

  2008cited by this paper
• The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB

  2008cited by this paper
• NEUROSERPIN MUTATION CAUSES ELECTRICAL STATUS EPILEPTICUS OF SLOW-WAVE SLEEP

  2008cited by this paper
• A structural basis for loop C-sheet polymerization in serpins.

  2008cited by this paper
• Probing the local conformational change of α1‐antitrypsin

  2007cited by this paper
• Probing the local conformational change of alpha1-antitrypsin.

  2007cited by this paper
• Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates.

  2007influential reference
• The Selective Advantage of 1-Antitrypsin Deficiency

  2006cited by this paper
• X‐ray crystal structure of MENT: evidence for functional loop–sheet polymers in chromatin condensation

  2006cited by this paper
• The selective advantage of alpha1-antitrypsin deficiency.

  2006cited by this paper
• Alpha 1-antitrypsin polymerization: a fluorescence correlation spectroscopic study.

  2005cited by this paper
• Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects

  2005cited by this paper
• Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo.

  2005cited by this paper
• Homozygous Deficiency of Heparin Cofactor II: Relevance of P17 Glutamate Residue in Serpins, Relationship With Conformational Diseases, and Role in Thrombosis

  2004cited by this paper
• Mutants of Neuroserpin That Cause Dementia Accumulate as Polymers within the Endoplasmic Reticulum*

  2004cited by this paper
• Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant.

  2004cited by this paper
• Lack of Effect of Oral 4-Phenylbutyrate on Serum Alpha-1-Antitrypsin in Patients with α-1-Antitrypsin Deficiency: A Preliminary Study

  2004cited by this paper
• Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB.

  2004cited by this paper
• Inhibiting polymerization: new therapeutic strategies for Z alpha1-antitrypsin-related emphysema.

  2004cited by this paper
• Different conformational changes within the F-helix occur during serpin folding, polymerization, and proteinase inhibition.

  2004cited by this paper
• How small peptides block and reverse serpin polymerisation.

  2004cited by this paper
• Targeting a Surface Cavity of α1-Antitrypsin to Prevent Conformational Disease

  2003cited by this paper
• Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis.

  2003cited by this paper
• Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease.

  2003cited by this paper
• Elucidation of the molecular logic by which misfolded α1-antitrypsin is preferentially selected for degradation

  2003cited by this paper
• Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema.

  2002cited by this paper
• Association between conformational mutations in neuroserpin and onset and severity of dementia.

  2002cited by this paper
• 6-mer Peptide Selectively Anneals to a Pathogenic Serpin Conformation and Blocks Polymerization

  2002cited by this paper
• Mutant Neuroserpin (S49P) That Causes Familial Encephalopathy with Neuroserpin Inclusion Bodies Is a Poor Proteinase Inhibitor and Readily Forms Polymers in Vitro *

  2002cited by this paper
• Acid Denaturation of alpha1-antitrypsin: characterization of a novel mechanism of serpin polymerization.

  2002cited by this paper
• Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency.

  2001cited by this paper
• Pathogenic α1-Antitrypsin Polymers are Formed by Reactive Loop-β-Sheet a Linkage

  2000cited by this paper
• Heteropolymerisation of I, S and Z α 1 -Antitrypsin and Liver Cirrhosis

  2000cited by this paper
• Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency.

  2000cited by this paper
• Topography of a 2.0 Å structure of α1‐antitrypsin reveals targets for rational drug design to prevent conformational disease

  2000cited by this paper
• Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease.

  2000cited by this paper
• Structure of a serpin–protease complex shows inhibition by deformation

  2000cited by this paper
• Pathogenic α1-Antitrypsin Polymers Are Formed by Reactive Loop-β-Sheet A Linkage*

  2000cited by this paper
• A Kinetic Mechanism for the Polymerization of α1-Antitrypsin*

  1999cited by this paper
• Familial dementia caused by polymerization of mutant neuroserpin

  1999cited by this paper
• Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis

  1999cited by this paper
• The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion.

  1999cited by this paper
• Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis.

  1999cited by this paper
• The mechanism of alpha 1-antitrypsin polymerization probed by fluorescence spectroscopy.

  1998cited by this paper
• Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema.

  1998cited by this paper
• Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation.

  1998cited by this paper
• Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin.

  1998cited by this paper
• The Mechanism of α1-Antitrypsin Polymerization Probed by Fluorescence Spectroscopy

  1998cited by this paper
• Neuroserpin, a Brain-associated Inhibitor of Tissue Plasminogen Activator Is Localized Primarily in Neurons

  1997cited by this paper
• Epidermal Growth Factor (EGF)-induced Generation of Hydrogen Peroxide

  1997cited by this paper
• Folding and Stability of the Z and Siiyama Genetic Variants of Human α1-Antitrypsin*

  1997cited by this paper
• Folding and stability of the Z and S(iiyama) genetic variants of human alpha1-antitrypsin.

  1997cited by this paper
• Inhibitory conformation of the reactive loop of alpha 1-antitrypsin.

  1996cited by this paper
• Inhibitory conformation of the reactive loop of α1-antitrypsin

  1996cited by this paper
• Degradation of a Mutant Secretory Protein, α1-Antitrypsin Z, in the Endoplasmic Reticulum Requires Proteasome Activity*

  1996cited by this paper
• The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A.

  1996cited by this paper
• Structural explanation for the deficiency of S alpha 1-antitrypsin.

  1996cited by this paper
• Structural explanation for the deficiency of S α1-antitrypsin

  1996cited by this paper
• A FAMILIAL DEMENTIA WITH UNUSUAL NEURONAL INCLUSIONS

  1996cited by this paper
• COOH-terminal Substitutions in the Serpin C1 Inhibitor That Cause Loop Overinsertion and Subsequent Multimerization (*)

  1995cited by this paper
• Preparation and Characterization of Latent α1-Antitrypsin (*)

  1995cited by this paper
• alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization.

  1995cited by this paper
• The Z type variation of human alpha 1-antitrypsin causes a protein folding defect.

  1995cited by this paper
• Preparation and characterization of latent alpha 1-antitrypsin.

  1995cited by this paper
• The Z type variation of human α1-antitrypsin causes a protein folding defect

  1995cited by this paper
• Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp)

  1994cited by this paper
• Biological implications of a 3 A structure of dimeric antithrombin.

  1994cited by this paper
• The molecular basis of alpha 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease.

  1993cited by this paper
• A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease.

  1993cited by this paper
• Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis.

  1993cited by this paper
• A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule.

  1993cited by this paper
• The molecular basis of α1-antichymotrypsin deficiency in a heterozygote with liver and lung disease

  1993cited by this paper
• Alpha 1-antitrypsin Siiyama (Ser53-->Phe). Further evidence for intracellular loop-sheet polymerization.

  1993cited by this paper
• The mechanism of Z α1-antitrypsin accumulation in the liver

  1993influential reference
• Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin.

  1993cited by this paper
• The mechanism of Z alpha 1-antitrypsin accumulation in the liver.

  1992cited by this paper

• Spatial covariance reveals isothiocyanate natural products adjust redox stress to restore function in alpha-1-antitrypsin deficiency

  2025cites this paper
• Alpha-1 Antitrypsin Deficiency in Children. A Modern View of the Problem

  2024cites this paper
• AAT: does it have a place in acute leukemia?

  2023cites this paper
• Diffuse panniculitis in a teenage male with ZZ α1-antitrypsin deficiency

  2023cites this paper
• Cancer risk associated with alpha-1-antitrypsin deficiency: only large registries will give us the answer

  2022cites this paper
• Capturing the conversion of the pathogenic alpha-1-antitrypsin fold by ATF6 enhanced proteostasis.

  2022cites this paper
• Alpha-1 Antitrypsin Deficiency Associated Panniculitis.

  2021cites this paper
• Scaling Concepts in Serpin Polymer Physics

  2021cites this paper
• Utility of Transient Elastography for the Screening of Liver Disease in Patients with Alpha1-Antitrypsin Deficiency

  2021cites this paper
• Abnormalities of Hepatic Protein Metabolism

  2021cites this paper
• Living with the enemy: from protein-misfolding pathologies we know, to those we want to know.

  2021cites this paper
• Pathophysiological aspects of liver damage in children with alpha-1-antitrypsin deficiency

  2020cites this paper
• Electronic Health Record–Based Prediction of 1-Year Risk of Incident Cardiac Dysrhythmia: Prospective Case-Finding Algorithm Development and Validation Study (Preprint)

  2020cites this paper
• Патофизиологические аспекты поражения печени у детей при недостаточности альфа-1-антитрипсина

  2020cites this paper
• Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians.

  2019cites this paper
• Alpha1-Antitrypsin Deficiency: Transition of Care for the Child With AAT Deficiency into Adulthood

  2019cites this paper
• Alpha-1 antitrypsin deficiency: outstanding questions and future directions

  2018cites this paper
• Association of alpha-1 antitrypsin level and lung function in patients with chronic obstructive pulmonary disease

  2017cites this paper
• Current Research and Future Perspectives

  2017cites this paper
• Actualización del algoritmo de diagnóstico de laboratorio del déficit de alfa-1-antitripsina : incorporación de la detección genotípica de la variante deficitaria Mmalton y utilización de muestras alternativas a la sangre total

  2017cites this paper
• Genetic diagnosis of α1-antitrypsin deficiency using DNA from buccal swab and serum samples

  2017cites this paper
• Rapid detection of Mmalton α1-antitrypsin deficiency allele by real-time PCR and melting curves in whole blood, serum and dried blood spot samples

  2016cites this paper
• IgE-tailpiece associates with α-1-antitrypsin (A1AT) to protect IgE from proteolysis without compromising its ability to interact with FcεRI

  2016cites this paper
• Managing the Adaptive Proteostatic Landscape: Restoring Resilience in Alpha-1 Antitrypsin Deficiency

  2016cites this paper
• Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach

  2016cites this paper
• Stability and Aggregation Studies of Immature Superoxide Dismutase

  2015influential citation
• Many roads lead to Rome? Multiple modes of Cu,Zn superoxide dismutase destabilization, misfolding and aggregation in amyotrophic lateral sclerosis.

  2014cites this paper
• Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls

  2014cites this paper
• Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z α1-antitrypsin

  2013cites this paper
• Les 50 ans de la découverte du déficit en alpha-1 antitrypsine

  2013cites this paper
• expressing Z α1-antitrypsin

  2013cites this paper